Impaact4tb - The Aurum Institute

Fundação Aurum partners with Mozambican government to help end TB

Mozambique has shown its commitment to ending TB, with Prime Minister Carlos Agostinho do Rosário, attending the launch of the rollout of a new TB prevention therapy (TPT) recently. The Aurum Instit...
Improving availability of patient-friendly tuberculosis preventive therapy

Global partners working to tackle the tuberculosis (TB) epidemic have announced the latest in a package of measures to increase supply security and availability of a short-course TB preventive therapy...
Shorter weekly course of rifapentine-isoniazid associated with much higher treatment completion rates compared to longer daily course

A randomized trial found that treatment completion was higher among HIV-positive persons who were assigned a shorter course of rifapentine-isoniazid therapy to prevent tuberculosis disease compared to...
TB Prevention in People With HIV: How Short Can We Go?

...
Call to action for an invigorated drive to scale up TB prevention

...
The Aurum Institute at the 52nd Union World Conference on Lung Health

Aurum has extensive experience in TB research, specifically TB treatment clinical trials, TB prevention trials with vaccines, preventive therapy, epidemiological studies, implementation research an...
Opt4TPT South Africa study team recruits and enrols participants

On 16 September 2021, the Opt4TPT study team in South Africa implemented by The Aurum Institute, started enrolling patients visiting the Chiawelo Community Health Centre (CHC) for antiretroviral the...
IMPAACT4TB Project statement responding to the WHO Global TB Report 2021

IMPAACT4TB Welcomes Gains in TB Prevention Among People Living With HIV, But Calls for Urgent Action to Address TB Prevention Deficits Among Children and Household Contacts of People Affected by TB ...
Concern as TB Preventative Treatment Declines

...
Aurum at 21st ICASA

Aurum was at the 21st International Conference on AIDS and Sexually Transmitted Infections (STIs) in Africa (ICASA). This year themed; The race to 2030 – Evidence. Scale Up. Accelerate, the conferen...
The Aurum Institute World TB Day Press Release

JOHANESBURG (24 MARCH 2022) Today, on World Tuberculosis Day, The Aurum Institute acknowledges the progress made and the challenges that lie ahead in efforts to end tuberculosis (TB). While COVID-19 h...
Invest more into combating TB, says Aurum Institute

...
Availability of 3HP Tuberculosis treatment in Ghana great news – Aurum Institute

...
2022 World TB Day: Aurum Institute Ghana appeals for positive investments to save lives

...
Aurum at Forum on Microbial Threats workshop

Aurum Group CEO Prof Gavin Churchyard presented at the Forum on Microbial Threats workshop recently. The Forum which is part of the National Academies of Sciences, Engineering, and Medicine, brought...
Aurum Institute Ghana: Making significant contributions towards Ghana’s healthcare services.

Aurum Institute Ghana, a proudly African organisation working to advance health science and innovation has reached a milestone of five years of operation in Ghana.  Aurum Ghana is part of T...
Zimbabwe reviews implementation of TB Preventive Therapy

...
Aurum Annual Report 2021

Aurum Board Chairperson Ms Phangisile Mtshali characterises 2021 as a year of adapting and building resilience. She writes in the Aurum Annual Report 2021, that the organisation had to pivot and seiz...
Partners announce reduced price for patient-friendly tuberculosis preventive treatments

August 1, 2022: Unitaid, The Aurum Institute, the Clinton Health Access Initiative (CHAI) and MedAccess today announced two new agreements to lower the price of rifapentine (RPT)-based treatments to p...
Global Consortium welcomes reduced price for patient-friendly treatment to prevent tuberculosis

...